Sign in
4

Changes in Ownership

Cardiff Oncology, Inc. Filed Acc 0001628280-24-030636

Options or other derivatives

  • Director acquired 29,700 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Markin Rodney S Director 2024-06-27 Grant or award · Stock Options +29,700 182,027 D
Loading xslF345X05/wk-form4_1719864512.xml…